Arizona State Retirement System’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-42,481
Closed -$90.5K 2088
2024
Q4
$90.5K Buy
42,481
+3,404
+9% +$8.39K ﹤0.01% 2097
2024
Q3
$109K Sell
39,077
-1,838
-4% -$4.9K ﹤0.01% 2095
2024
Q2
$95.3K Buy
40,915
+10,855
+36% +$32K ﹤0.01% 2055
2024
Q1
$134K Sell
30,060
-398
-1% -$1.66K ﹤0.01% 2033
2023
Q4
$97.8K Buy
30,458
+5,543
+22% +$15.7K ﹤0.01% 2101
2023
Q3
$79K Buy
24,915
+563
+2% +$2.47K ﹤0.01% 2104
2023
Q2
$121K Sell
24,352
-719
-3% -$3.89K ﹤0.01% 2085
2023
Q1
$124K Buy
25,071
+724
+3% +$4.64K ﹤0.01% 2073
2022
Q4
$153K Buy
24,347
+933
+4% +$8.64K ﹤0.01% 2002
2022
Q3
$253K Buy
23,414
+202
+0.9% +$2.75K ﹤0.01% 1740
2022
Q2
$265K Buy
23,212
+2,024
+10% +$18K ﹤0.01% 1751
2022
Q1
$193K Buy
21,188
+140
+0.7% +$1.46K ﹤0.01% 2027
2021
Q4
$314K Sell
21,048
-157
-0.7% -$2.77K ﹤0.01% 1809
2021
Q3
$545K Buy
21,205
+177
+0.8% +$4.2K ﹤0.01% 1492
2021
Q2
$548K Buy
21,028
+2,652
+14% +$75.6K ﹤0.01% 1521
2021
Q1
$649K Buy
18,376
+199
+1% +$6.71K 0.01% 1397
2020
Q4
$459K Buy
18,177
+1,161
+7% +$37.8K ﹤0.01% 1499
2020
Q3
$642K Buy
17,016
+4,329
+34% +$163K 0.01% 1154
2020
Q2
$543K Buy
+12,687
New +$459K 0.01% 1079

Other funds holding ALLO

Arizona State Retirement System's ALLO Position: Q1 2025 in Review

Arizona State Retirement System sold out of Allogene Therapeutics (ALLO) in Q1 2025, closing a stake of 42,481 shares — an estimated $90.5K sold.

Arizona State Retirement System first reported a position in ALLO in Q2 2020 and held it in 19 quarters. The position peaked at $649K in Q1 2021. 170 funds tracked by Wall St. Rank hold ALLO as of Q1 2025.

  • Arizona State Retirement System reported no remaining Allogene Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Arizona State Retirement System sold 42,481 Allogene Therapeutics shares in Q1 2025, an estimated $90.5K.
  • Arizona State Retirement System first reported a position in Allogene Therapeutics in Q2 2020 and held it in 19 quarters.
  • Arizona State Retirement System's Allogene Therapeutics position peaked at $649K in Q1 2021.
  • 170 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2025.

Based on Arizona State Retirement System's 13F filing for Q1 2025, filed 1 May 2025.